Metraipolis › archive › dc_e80ebb9eae7c
Optimizing rhBMP-2 Therapy for Bone Regeneration: From Safety Concerns to Biomaterial-Guided Delivery Systems — Europe PMC PMID:41226759
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41226759
- DOI
- 10.3390/ijms262110723
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T19:35:41.437Z
- SHA-256 of the archived text
bb7792bf7bcc32d9e862d067fa48345e79a0928f2400ef1a16e058b5eada97de- Stable URL of this page
https://metraipolis.com/documento/dc_e80ebb9eae7c
How to cite
Optimizing rhBMP-2 Therapy for Bone Regeneration: From Safety Concerns to Biomaterial-Guided Delivery Systems — Europe PMC PMID:41226759 — Europe PMC (en), https://europepmc.org/article/MED/41226759 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e80ebb9eae7c (Metraipolis archive dc_e80ebb9eae7c, sha256 bb7792bf7bcc32d9e862d067fa48345e79a0928f2400ef1a16e058b5eada97de)
BibTeX
@misc{dce80ebb9eae7c,
title = {Optimizing rhBMP-2 Therapy for Bone Regeneration: From Safety Concerns to Biomaterial-Guided Delivery Systems — Europe PMC PMID:41226759},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41226759},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e80ebb9eae7c; sha256 bb7792bf7bcc32d9e862d067fa48345e79a0928f2400ef1a16e058b5eada97de},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41226759. Agents can read the archived copy with the MCP tool read_document.